Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |